SIGN UP
LOG IN
MARKET
CLGN
CLGN
Collplant Biotechnologies Ltd
NASDAQ
5.20
-0.02
-0.38%
After Hours: 5.22 +0.02 +0.38% 16:00 04/19 EDT
OPEN
5.22
PREV CLOSE
5.22
HIGH
5.22
LOW
5.20
VOLUME
1.23K
TURNOVER
0
52 WEEK HIGH
8.90
52 WEEK LOW
4.220
MARKET CAP
59.56M
P/E (TTM)
-8.4374
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CLGN last week (0408-0412)?
Weekly Report · 4d ago
Weekly Report: what happened at CLGN last week (0401-0405)?
Weekly Report · 04/08 11:58
Buy Rating Affirmed for Collplant Holdings on Strong Financials and Promising Product Pipeline Advancements
TipRanks · 04/05 10:25
Collplant Biotechnologies Price Target Maintained With a $11.00/Share by HC Wainwright & Co.
Dow Jones · 04/05 10:17
HC Wainwright & Co. Reiterates Buy on CollPlant Biotechnologies, Maintains $11 Price Target
Benzinga · 04/05 10:07
CLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023
CollPlant Biotechnologies reported earnings per share of -35 cents for the fourth quarter of 2023. The company reported revenue of $299,000. This was 96.51% worse than the analyst estimate for revenue of $8.56 million.
Investorplace · 04/04 15:52
CollPlant Biotechnologies’ Strong Financial and R&D Progress
TipRanks · 04/04 11:57
CollPlant Biotechnologies Q4 Adj EPS $(0.35) Misses $(0.07) Estimate, Sales $299.00K Miss $8.56M Estimate
CollPlant Biotechnologies reported quarterly sales of $299.00 million. The company missed the analyst consensus estimate of $8.56 million by 96.51%. The company also reported quarterly losses of $0.35 per share and missed the consensus estimate by 400 percent.
Benzinga · 04/04 11:22
About CLGN
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Webull offers Collplant Biotechnologies Ltd - ADR stock information, including NASDAQ: CLGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading CLGN stock methods without spending real money on the virtual paper trading platform.